Last edition
News about "Fresenius Kabi "
Polpharma Biologics, Fresenius Kabi Partners to Commercialise A Proposed Vedolizumab Biosimilar
Polpharma Biologics, a European biotechnology company, has entered into a global licensing agreement with German multinational healthcare firm Fresenius Kabi for the commercialisation of PB016—a proposed biosimilar to vedolizumab.
Fresenius Kabi | 06/08/2025 | By Dineshwori | 110
Cellular Origins, Fresenius Kabi to Scale Up Automation of Cell and Gene Therapy Manufacturing
The agreement is designed with the goal of digitally and physically integrating Fresenius Kabi’s suite of cell therapy processing technologies within Cellular Origins’ CGT robotic manufacturing platform Constellation.
Fresenius Kabi | 17/10/2024 | By Aishwarya | 232
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy